Pure Biologics S.A. (WSE:PUR)
Poland
· Delayed Price · Currency is PLN 8.78
-0.22 (-2.44%)
May 14, 2025, 11:44 AM CET
Pure Biologics Balance Sheet
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
| Cash & Equivalents | 0.31 | 3.61 | 2.26 | 6.18 | 8.96 | Upgrade
|
| Short-Term Investments | - | - | 4.92 | 26.75 | - | Upgrade
|
| Cash & Short-Term Investments | 0.31 | 3.61 | 7.18 | 32.93 | 8.96 | Upgrade
|
| Cash Growth | -91.32% | -49.76% | -78.20% | 267.68% | -35.67% | Upgrade
|
| Accounts Receivable | 1.67 | 0.02 | 0.15 | 0.05 | 0.02 | Upgrade
|
| Other Receivables | - | 14.73 | 15.07 | 9.24 | 1.34 | Upgrade
|
| Receivables | 1.67 | 14.75 | 15.22 | 9.29 | 1.35 | Upgrade
|
| Prepaid Expenses | - | 0.03 | 0.02 | 0.03 | 0.02 | Upgrade
|
| Other Current Assets | 0.12 | 3.22 | 1.76 | 0.77 | 2.71 | Upgrade
|
| Total Current Assets | 2.11 | 21.6 | 24.17 | 43.02 | 13.04 | Upgrade
|
| Property, Plant & Equipment | 0.12 | 3.7 | 8.42 | 3.45 | 4.88 | Upgrade
|
| Long-Term Investments | - | - | 0.02 | 0.02 | - | Upgrade
|
| Other Intangible Assets | 0.12 | 0.26 | 0.29 | 0.33 | 0.37 | Upgrade
|
| Long-Term Deferred Charges | - | - | 0.11 | 0.39 | 0.65 | Upgrade
|
| Other Long-Term Assets | - | -2.82 | - | - | - | Upgrade
|
| Total Assets | 2.34 | 22.74 | 33.01 | 47.19 | 18.94 | Upgrade
|
| Accounts Payable | 0.85 | 1.03 | 7.24 | 0.67 | 2.76 | Upgrade
|
| Accrued Expenses | 0.35 | 0.92 | 1.64 | 0.08 | 1.49 | Upgrade
|
| Current Portion of Long-Term Debt | 13.96 | - | - | - | - | Upgrade
|
| Current Portion of Leases | 0.1 | 0.09 | 1.1 | 1.11 | 1.38 | Upgrade
|
| Current Unearned Revenue | - | 4.81 | 2.79 | 3.68 | 12.23 | Upgrade
|
| Other Current Liabilities | 0.2 | 1.15 | 0.08 | 0 | 0.15 | Upgrade
|
| Total Current Liabilities | 15.46 | 7.99 | 12.83 | 5.55 | 18 | Upgrade
|
| Long-Term Debt | - | 12.72 | - | - | - | Upgrade
|
| Long-Term Leases | - | 0.13 | 1.77 | 2 | 3.63 | Upgrade
|
| Long-Term Unearned Revenue | - | - | 0.07 | 0.11 | 0.15 | Upgrade
|
| Other Long-Term Liabilities | - | - | - | 0 | 0 | Upgrade
|
| Total Liabilities | 15.46 | 20.85 | 14.71 | 7.7 | 21.83 | Upgrade
|
| Common Stock | 0.38 | 0.33 | 0.23 | 0.23 | 0.17 | Upgrade
|
| Additional Paid-In Capital | - | 90.57 | 75.31 | 70.89 | 16.82 | Upgrade
|
| Retained Earnings | -112.36 | -92.93 | -57.24 | -31.63 | -19.87 | Upgrade
|
| Comprehensive Income & Other | 98.87 | 3.92 | 0 | - | 0 | Upgrade
|
| Shareholders' Equity | -13.12 | 1.89 | 18.3 | 39.49 | -2.89 | Upgrade
|
| Total Liabilities & Equity | 2.34 | 22.74 | 33.01 | 47.19 | 18.94 | Upgrade
|
| Total Debt | 14.06 | 12.94 | 2.86 | 3.11 | 5.01 | Upgrade
|
| Net Cash (Debt) | -13.75 | -9.33 | 4.32 | 29.82 | 3.95 | Upgrade
|
| Net Cash Growth | - | - | -85.52% | 654.64% | -53.78% | Upgrade
|
| Net Cash Per Share | - | -2.93 | 1.92 | 13.42 | 2.39 | Upgrade
|
| Filing Date Shares Outstanding | - | 3.33 | 2.25 | 2.25 | 1.65 | Upgrade
|
| Total Common Shares Outstanding | - | 3.33 | 2.25 | 2.25 | 2.25 | Upgrade
|
| Working Capital | -13.35 | 13.61 | 11.34 | 37.47 | -4.96 | Upgrade
|
| Book Value Per Share | - | 0.57 | 8.12 | 17.52 | -1.28 | Upgrade
|
| Tangible Book Value | -13.23 | 1.64 | 18.01 | 39.16 | -3.26 | Upgrade
|
| Tangible Book Value Per Share | - | 0.49 | 7.99 | 17.37 | -1.45 | Upgrade
|
| Land | - | - | 0.1 | 0.87 | - | Upgrade
|
| Machinery | - | 11.25 | 11.95 | 10.95 | 9.88 | Upgrade
|
Updated Nov 15, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.